Abstract
Transcortical dialysis was employed to investigate the effects of subcutaneous (s.c.) injections of RJR-2403 (1.2-7.2 mumol/kg) on extracellular levels of acetylcholine (ACh), norepinephrine (NE), dopamine (DA), and serotonin (5-HT) in rat. Systemic administration of RJR-2403 produced a 90% increase of cortical extracellular ACh levels that persisted for up to 90 minutes after injection. Norepinephrine and DA release were increased 124% and 131% above basal values, respectively. Serotonin (5-HT) levels in the dialysate were also significantly elevated by RJR-2403 (3.6 mumol/kg, s.c.) 70% above baseline at 90 minutes post-injection. Comparison of these responses to those of (-)nicotine from a previous study reveals little difference between the two compounds in their ability to influence cortical neurotransmitter release following systemic administration.
MeSH Terms
Acetylcholine/metabolism
Animals
Biogenic Amines/metabolism
Cerebral Cortex/drug effects,metabolism
Dopamine/metabolism
Dose-Response Relationship, Drug
Male
Microdialysis
Nicotine/analogs & derivatives,pharmacology
Nicotinic Agonists/pharmacology
Norepinephrine/metabolism
Rats
Rats, Sprague-Dawley
Serotonin/metabolism
Chemicals
Biogenic Amines
Nicotinic Agonists
Serotonin
metanicotine
Nicotine
Acetylcholine
Dopamine
Norepinephrine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Summers K L
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield 62794-1222, USA.
Lippiello P
Giacobini E
References (24)
24 references, click to expand
-
Pharmacological consequences of nicotinergic plus serotonergic manipulations.
Brain Res. 1993 Sep 17;622(1-2):139-46
PMID: 8242353
-
Studies of protective actions of nicotine on neuronal and vascular functions in the brain of rats: comparison between sympathetic noradrenergic and mesostriatal dopaminergic fiber systems, and the effect of a dopamine agonist.
Prog Brain Res. 1989;79:267-76
PMID: 2573912
-
D1 dopamine receptors in prefrontal cortex: involvement in working memory.
Science. 1991 Feb 22;251(4996):947-50
PMID: 1825731
-
Improved method for the routine analysis of acetylcholine release in vivo: quantitation in the presence and absence of esterase inhibitor.
J Chromatogr. 1993 Dec 22;622(2):125-35
PMID: 8150861
-
Nicotinic systems and cognitive function.
Psychopharmacology (Berl). 1992;108(4):417-31
PMID: 1357713
-
Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro.
Neuroscience. 1986 Oct;19(2):565-71
PMID: 2430232
-
Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.
Life Sci. 1994;54(16):1169-84
PMID: 8152341
-
Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
Acta Physiol Scand. 1988 Apr;132(4):589-91
PMID: 3265840
-
Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity.
Brain Res. 1994 May 2;644(2):181-7
PMID: 7519524
-
Intravenous nicotine in a patient with Alzheimer's disease.
Am J Psychiatry. 1986 Nov;143(11):1494-5
PMID: 3777262
-
Cortical noradrenaline, attention and arousal.
Psychol Med. 1984 Feb;14(1):13-21
PMID: 6709778
-
5-fluoronicotine, noranhydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo.
Neurochem Res. 1995 Sep;20(9):1089-94
PMID: 8570014
-
Effects of nicotine and its major metabolites on blood pressure in anaesthetized rats.
Klin Wochenschr. 1985 Jan 15;63(2):90-2
PMID: 3981953
-
Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain.
J Neurochem. 1984 May;42(5):1495-8
PMID: 6707650
-
Biochemical characterization of the nicotinic cholinergic receptors in human brain: binding of (-)-[3H]nicotine.
J Neurochem. 1985 Aug;45(2):604-10
PMID: 2861250
-
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.
Psychoneuroendocrinology. 1990;15(5-6):471-84
PMID: 1966302
-
Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain.
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8697-701
PMID: 3317419
-
Mesocorticolimbic dopaminergic network: functional and regulatory roles.
Physiol Rev. 1991 Jan;71(1):155-234
PMID: 1986388
-
Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor.
Psychopharmacology (Berl). 1983;81(1):54-60
PMID: 6415731
-
Neurotransmitters and neuropeptides in Alzheimer's disease.
Psychiatr Clin North Am. 1991 Jun;14(2):421-42
PMID: 1676509
-
Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex.
Neurochem Res. 1995 Jun;20(6):753-9
PMID: 7566373
-
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.
Psychopharmacology (Berl). 1992;108(4):485-94
PMID: 1410164
-
Genetic influences on nicotine responses.
Pharmacol Biochem Behav. 1989 Jul;33(3):667-78
PMID: 2587608
-
The effects of nicotine on brain neurotransmitter systems.
Pharmacol Ther. 1982;16(2):269-82
PMID: 6127728